22-36228077-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_030882.4(APOL2):​c.341C>T​(p.Thr114Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000787 in 1,614,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000042 ( 0 hom. )

Consequence

APOL2
NM_030882.4 missense

Scores

2
5
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.51
Variant links:
Genes affected
APOL2 (HGNC:619): (apolipoprotein L2) This gene is a member of the apolipoprotein L gene family. The encoded protein is found in the cytoplasm, where it may affect the movement of lipids or allow the binding of lipids to organelles. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10508269).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
APOL2NM_030882.4 linkuse as main transcriptc.341C>T p.Thr114Ile missense_variant 5/5 ENST00000358502.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
APOL2ENST00000358502.10 linkuse as main transcriptc.341C>T p.Thr114Ile missense_variant 5/51 NM_030882.4 P2
APOL2ENST00000249066.10 linkuse as main transcriptc.341C>T p.Thr114Ile missense_variant 6/61 P2
APOL2ENST00000451256.6 linkuse as main transcriptc.677C>T p.Thr226Ile missense_variant 6/62 A2
APOL2ENST00000529194.5 linkuse as main transcriptc.341C>T p.Thr114Ile missense_variant 5/53

Frequencies

GnomAD3 genomes
AF:
0.000427
AC:
65
AN:
152248
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00140
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000878
AC:
22
AN:
250512
Hom.:
0
AF XY:
0.0000885
AC XY:
12
AN XY:
135628
show subpopulations
Gnomad AFR exome
AF:
0.00113
Gnomad AMR exome
AF:
0.0000868
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000882
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000424
AC:
62
AN:
1461884
Hom.:
0
Cov.:
35
AF XY:
0.0000399
AC XY:
29
AN XY:
727242
show subpopulations
Gnomad4 AFR exome
AF:
0.00137
Gnomad4 AMR exome
AF:
0.0000894
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000450
Gnomad4 OTH exome
AF:
0.000116
GnomAD4 genome
AF:
0.000427
AC:
65
AN:
152366
Hom.:
0
Cov.:
33
AF XY:
0.000403
AC XY:
30
AN XY:
74520
show subpopulations
Gnomad4 AFR
AF:
0.00139
Gnomad4 AMR
AF:
0.000261
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000188
Hom.:
0
Bravo
AF:
0.000476
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000824
AC:
10
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 06, 2021The c.341C>T (p.T114I) alteration is located in exon 6 (coding exon 3) of the APOL2 gene. This alteration results from a C to T substitution at nucleotide position 341, causing the threonine (T) at amino acid position 114 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.52
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
.;.;T;.
Eigen
Uncertain
0.32
Eigen_PC
Benign
0.15
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Uncertain
0.91
.;D;D;D
M_CAP
Benign
0.0041
T
MetaRNN
Benign
0.11
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
0.98
N;N;N
PrimateAI
Benign
0.39
T
PROVEAN
Pathogenic
-5.6
D;D;D;D
REVEL
Benign
0.20
Sift
Pathogenic
0.0
D;D;D;T
Sift4G
Benign
0.098
T;T;T;.
Vest4
0.23
MVP
0.35
MPC
0.42
ClinPred
0.77
D
GERP RS
2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201222628; hg19: chr22-36624123; API